Recs
October 22, 2013 – Comments (20)
update of the usual figure displaying the S&P 500 index (see this post).
enlarge
short explanation.
I was looking at this chart and it looks like you started it at the bottom of the last crash. I was wondering what a chart would look like if you drew it using the same formulas but starting at a different crash?
Well he made it back then for all the bears and bulls that were screaming at each other. I thought the chart line did a structural shift in 2011 during the whole Congress Red Swan debacle, but it seems to have gotten back on track.
#1 see comments #11,22,40,41,52 here.
http://caps.fool.com/Blogs/ellipsis/219380.
My favourites are #40 and #41 :)
----------------
#40) On July 17, 2009 at 11:06 AM, portefeuille (99.80) wrote:
USDRUB
(The spike in 1998 in not an error, it is the start of the Russian/Asian/LTCM crisis.)
#41) On July 18, 2009 at 1:30 AM, portefeuille (99.80) wrote:
USDZAR
biopharma is still doing great.
my old fund vs. benchmark ETFs.
https://twitter.com/portefeuillefun.https://twitter.com/search?q=%23zzporte&src=hash&f=realtime.
update.
And the biopharma rally continues :)
I don't suppose you would like to invest a bit of my money for me, would you? ;)
No, no outside investors yet. I think you can continue holding your IBB ETF, though, it is "relatively safe", at least for a biotech investment.
Well, you can't blame a gal for trying!
Oh Porte me buddy we need an updated chart please ;)
I don't have access to my spreadsheet currently.
You can calculate the trend line and trend channel easily, see comments #2,6 here.
http://caps.fool.com/Blogs/chart/667955.
Just enter the appropriate number for trading day and then let google, wolfram alpha or your favourite spreadsheet do the calculation. Trading day is what is shown on the x-axis in "my chart" ...
Still biopharma, right? Happy New Year, Porte!
#15 Yes, still into biopharma equities. If you still or again have IBB I think you can keep it for a few more years. Even CRME is trying to make a comeback. Happy New Year!
continued here.
View More